Donald receives $3M Established Investigator MIRA award
Bruce Donald, PhD, has received a five year, $2.9 million Established Investigator Maximizing Investigators’ Research Award (MIRA)
Pilot funding launches new wave of COVID research
The Duke University School of Medicine Precision Genomics Collaboratory awarded $15,000 pilot grants to young investigators in January 2021. These grants focused on COVID-19 research that broadly involved genetics and genomics. One year later, these young investigators are in the thick of cutting-edge research.
Your gut senses the difference between real sugar and artificial sweetener
Sugar preference isn’t just a matter of taste - it’s deeper than that
PGC Announces Student Pilot Grant Awardees
The Duke University School of Medicine Office of Biomedical and Graduate Education (OBGE) and Precision Genomics Collaboratory awarded 10 pilot grants of $2,000 each to SOM Biomedical PhD students.
Tune Therapeutics: New Startup Co-founded by Gersbach Launches with Pioneering Epigenomic Control Platform to Master Gene Networks, Treat Broad Range of Diseases
Tune Therapeutics, a biotechnology company pioneering the creation of epi-therapeutic medicines, launched today with its powerful and precise genetic tuning platform, TEMPO. This cutting-edge technology dials gene expression up or down to desired levels – with the potential to reverse pathways of cancer, genetic disease, and aging by changing cell fate and function at will.
Watch: Lori Orlando's interview with WRAL on family health history
Lori Orlando, MD, MHS, MMCI, recently spoke with WRAL on the importance of talking with loved ones about family health history.
Six PGC faculty named on this year's 'Highly Cited Researchers' list
Peak achievement in the sciences isn’t measured by stopwatches or goals scored, it goes by citations – the number of times other scientists have referenced your findings in their own academic papers. A high number of citations is an indication that a particular work was influential in moving the field forward.
Duke Health designated a NORD Rare Disease Center of Excellence
The National Organization for Rare Disorders (NORD) has designated the Duke Health Rare Disease Center as a NORD Rare Disease Center of Excellence, joining a highly select group of 31 medical centers, nationwide, as part of an innovative network seeking to expand access and advance care and research for rare disease patients in the United States.
Duke researchers well represented at annual ASHG meeting
The American Society of Human Genetics (ASHG) is a professional organization for researchers and clinicians who specialize in human genetics. They work to advance human genetics and genomics in science, healthy and society through research, education and advocacy. The ASHG Annual Meeting was held October 18-22, and several members of the Precision Genomics Collaboratory presented their research: